// App-Quantinova.ai

805 : Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours

Researchers

Presenter

  • Mark Lythgoe

Principal Investigators

  • Justin Stebbing

  • Emily Pickford

  • Axel Glasmacher

  • Marsilio Adriani

  • Gayle Fyvie

  • Adam Frampton

  • Alex Stevenson

  • Jonathan Krell

Medical Centers

  • Imperial College London, London, NY

  • D pharma plc, Leeds, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved